| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 03/14/2013 | US20130066079 Forms of rifaximin and uses thereof |
| 03/14/2013 | US20130065932 Process for the isolation of organic compounds useful for the treatment of cancer |
| 03/14/2013 | US20130065908 Dihydrofuro pyrimidines as akt protein kinase inhibitors |
| 03/14/2013 | US20130065877 Substituted phenyl cycloalkyl pyrrolidine (piperidine) spirolactams and amides, preparation and therapeutic use thereof |
| 03/14/2013 | US20130065842 COMPOUNDS AS RORyT MODULATORS AND USES THEREOF |
| 03/14/2013 | CA2861150A1 Morphinan derivative |
| 03/14/2013 | CA2848148A1 Benzonitrile derivatives as kinase inhibitors |
| 03/14/2013 | CA2847728A1 Processes and intermediates for making a jak inhibitor |
| 03/13/2013 | EP2566870A1 New pro-drugs of amaryllidaceae isocarbostyril products and their use against brain tumors |
| 03/13/2013 | EP2566335A1 Controlled release from macromolecular conjugates |
| 03/13/2013 | CN102964344A Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same |
| 03/12/2013 | US8394974 Process for producing optically active chromene oxide compound |
| 03/12/2013 | US8394957 9-aminonoscapine and its use in treating cancers, including drug-resistant cancers |
| 03/12/2013 | US8394828 Quinoline-derived amide modulators of vanilloid VR1 receptor |
| 03/12/2013 | US8394817 CCR1 antagonists and methods of use therefor |
| 03/12/2013 | US8394629 Use of vinca alkaloids and salts thereof |
| 03/12/2013 | CA2697551C Piperidine derivatives as modulators of gpr119 activity |
| 03/12/2013 | CA2550350C 2-(hetero)aryl-substituted tetrahydroquinoline derivatives |
| 03/07/2013 | WO2013032284A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 03/07/2013 | WO2013030750A1 Antiviral compounds |
| 03/07/2013 | WO2012117000A8 3-amino-pyridines as gpbar1 agonists |
| 03/07/2013 | US20130060041 Synthesis of substituted pyrazoline carboxamidine derivatives |
| 03/07/2013 | US20130060037 Materials with aza-dibenzothiophene or aza-dibenzofuran core for pholed |
| 03/07/2013 | US20130060026 Processes and intermediates for making a jak inhibitor |
| 03/07/2013 | US20130060013 Compounds useful for treating neurodegenerative disorders |
| 03/07/2013 | US20130059863 Substituted n-heteroaryl spirolactam bipyrrolidines, preparation and therapeutic use thereof |
| 03/07/2013 | US20130059844 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 03/07/2013 | US20130059834 Pyrrolopyrazine kinase inhibitors |
| 03/07/2013 | US20130059832 Compounds and compositions as c-kit kinase inhibitors |
| 03/07/2013 | CA2844521A1 Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| 03/06/2013 | EP2565196A1 Prophylactic or therapeutic medication for inner ear disorders |
| 03/06/2013 | CN102958936A Anellated pyridine compounds |
| 03/06/2013 | CN102958918A Novel nicotinamide derivatives or salts thereof |
| 03/06/2013 | CN102952144A Crystal forms of asenapine maleate, and preparation method and medical composition thereof |
| 03/06/2013 | CN101817833B DPP-IV inhibitor |
| 03/06/2013 | CN101679273B 1-substituted tetrahydroisoquinoline compound |
| 03/05/2013 | US8389721 Solubilized topoisomerase poisons |
| 03/05/2013 | US8389564 Proteasome inhibitors |
| 03/05/2013 | US8389532 7-[2-[4-(6-fluoro-3-methyl-1,2-benzisoxazol-5-yl)-1-piperazinyl]ethyl]-2-(1-propynyl)-7H-pyrazolo-[4,3-E]-[1,2,4]-triazolo-[1,5-C]-pyrimidin-5-amine |
| 02/28/2013 | WO2013027801A1 Fused heterocyclic derivative and pharmaceutical use thereof |
| 02/28/2013 | WO2013026900A1 Pyridine derivatives as microbiocides |
| 02/28/2013 | WO2013026383A1 Tetrandrine derivatives with substituted 5-carbon, preparation method and use thereof |
| 02/28/2013 | US20130053555 Organic electroluminescent devices |
| 02/28/2013 | US20130053553 Heterocyclic compounds |
| 02/28/2013 | US20130053404 Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation |
| 02/28/2013 | US20130053386 Diaryl ether derivatives as notch sparing gamma secretase inhibitors |
| 02/28/2013 | US20130053377 Inhibitors of beta-secretase |
| 02/28/2013 | US20130053372 5-ht receptor modulators |
| 02/28/2013 | US20130053363 IMIDAZO[1,2-a]PYRIDINE DERIVATIVE |
| 02/28/2013 | US20130052138 Methods and compositions for diagnostic and therapeutic targeting of cox-2 |
| 02/27/2013 | EP2560976A1 Furopyridine compounds and uses thereof |
| 02/27/2013 | EP2143444A9 Compositions for inhibition of angiogenesis |
| 02/27/2013 | CN102947311A 3-oxo-3,9-dihydro-1h-chromeno[2,3-c]pyrroles as glucokinase activators |
| 02/27/2013 | CN102947310A Anellated pyridine compounds as dual modulators of the 5-HT2A and D3 receptors |
| 02/27/2013 | CN102947304A Compounds for electronic devices |
| 02/27/2013 | CN101851505B Coumarin organic electroluminescent fluorescent materials and synthesis method thereof |
| 02/27/2013 | CN101490057B Compositions and methods of making a photoactive agent |
| 02/26/2013 | US8383841 Phenyl xanthene dyes |
| 02/26/2013 | US8383814 Substituted tetrahydropyran spiro pyrrolidinone and piperidinone, preparation and therapeutic use thereof |
| 02/26/2013 | US8383644 Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof |
| 02/26/2013 | US8383643 Spiro compounds useful as inhibitors of stearoyl-coenzyme A delta-9 desaturase |
| 02/26/2013 | CA2655668C Aziridinyl-epothilone compounds |
| 02/26/2013 | CA2542076C Substituted tricyclic compounds as protein kinase inhibitors |
| 02/26/2013 | CA2523426C Aza spiro alkane derivatives as inhibitors of metalloproteases |
| 02/21/2013 | WO2013025733A1 Lysophosphatidic acid receptor antagonists |
| 02/21/2013 | WO2013024730A1 Organic electroluminescent element, compound for organic electroluminescent element, and light-emitting device, display device, and illumination device using said element |
| 02/21/2013 | WO2013024492A2 A process for the preparation of asenapine and novel salts thereof |
| 02/21/2013 | WO2013024149A1 Crystalline forms of octahydro-3h-spiro [furo [3, 4-c] quinoline -1, 4 '-pyran] -9-ol |
| 02/21/2013 | WO2013024130A1 Furo[3,4-c]quinoline derivatives, medicaments containing such compounds, their use and process for their preparation |
| 02/21/2013 | WO2013023622A1 Acylated derivative of homoharringtonine, preparation method therefor, and application thereof |
| 02/21/2013 | WO2013023620A1 Aminated derivative of homoharringtonine, preparation method therefor, and application thereof |
| 02/21/2013 | US20130045973 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 02/21/2013 | US20130045962 Peptide deformylase inhibitors |
| 02/21/2013 | CA2844982A1 Lysophosphatidic acid receptor antagonists |
| 02/20/2013 | CN102939292A Spirocyclic compounds and their use as therapeutic agents and diagnostic probes |
| 02/20/2013 | CN102939284A Agent for treating hcv infection |
| 02/19/2013 | US8377949 Quinazolinedione chymase inhibitors |
| 02/19/2013 | CA2572350C Tetrahydroquinolines |
| 02/14/2013 | WO2013021907A1 Organic electric light emitting element, material for said element, and light emitting device, display device, and illumination device employing said element |
| 02/14/2013 | WO2013021344A1 Imidazole derivatives as antiviral agents |
| 02/14/2013 | WO2013021337A1 Antiviral compounds with a fused tricyclic ring |
| 02/14/2013 | WO2013021044A1 1,2,4-triazolyl-substituted keto-enols |
| 02/14/2013 | WO2013020184A1 Flavonoid compounds, and methods of use thereof |
| 02/14/2013 | WO2013020164A1 Compounds for treating respiratory syncytial virus infections |
| 02/14/2013 | US20130040947 Trkb agonists and methods of use |
| 02/14/2013 | US20130040941 Benzodiazepine compound and pharmaceutical composition |
| 02/14/2013 | US20130040935 Cyclic keto-enols for therapy |
| 02/14/2013 | US20130040934 Spirocyclic compounds and their use as therapeutic agents and diagnostic probes |
| 02/14/2013 | US20130039904 Gambogic acid cyclization analogues, their preparation method and application thereof |
| 02/14/2013 | CA2855948A1 1,2,4-triazolyl-substituted keto-enols |
| 02/14/2013 | CA2844511A1 Flavonoid compounds, and methods of use thereof |
| 02/13/2013 | EP2556075A1 Substituted carbazole derivatives and use thereof in organic electronics |
| 02/13/2013 | CN102933582A Substituted carbazole derivatives and use thereof in organic electronics |
| 02/13/2013 | CN102933579A New ccr2 receptor antagonists and uses thereof |
| 02/13/2013 | CN102924377A Synthetic method of 3,4,5-substituted pyrazole compound |
| 02/12/2013 | US8372981 Nitrogen-containing aromatic derivatives |
| 02/12/2013 | US8372823 Tetracyclic inhibitors of fatty acid amide hydrolase |
| 02/12/2013 | CA2596527C Igf-1r inhibitors |
| 02/07/2013 | WO2013018695A1 Heterocyclic compound |
| 02/07/2013 | WO2013017026A1 Hcv protease inhibitors |